Key result
Sublingual nitroglycerin induced coronary artery dilatation, with the greatest magnitude of vasodilatation observed in arteries with the smallest control diameter.
Why the study?
Does sublingual nitroglycerin improve vasodilatation differently based on the baseline size and location of coronary arteries?
Population
34 patients undergoing coronary angiography, including those with and without coronary artery disease.
Comparison
Nitroglycerin 0.4 mg sublingual. vs Baseline measurements.
Design
Cohort
Authors
Loading...
Smaller arteries dilate more after nitroglycerin; leaves open whether baseline diameter should guide dosing in ischemia.
Does sublingual nitroglycerin improve vasodilatation differently based on the baseline size and location of coronary arteries?
The principal determinant of coronary artery vasodilatory response to sublingual nitroglycerin is the baseline size of the artery, with smaller vessels exhibiting greater dilatation.
Feldman et al. (1981) studied Patients undergoing coronary angiography (n=34). Nitroglycerin vs. Baseline (before nitroglycerin) was evaluated on Magnitude of dilatation of coronary arteries. Sublingual nitroglycerin induced coronary artery dilatation, with the greatest magnitude of vasodilatation observed in arteries with the smallest control diameter.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: